Skip to main content
Fig. 6 | Cardiovascular Diabetology

Fig. 6

From: Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor

Fig. 6

Subgroup analysis of hazard ratios for the risk of all-cause mortality (a) and cardiovascular mortality (b) for SGLT2i versus DPP4i among T2DM patients with peripheral artery disease after propensity score matching. The subgroup analysis revealed consistent results for all-cause mortality (a) and cardiovascular mortality (b) for SGLT2i versus DPP4i among patients aged ≥ 75 years, the presence of chronic kidney disease and established CV disease, consistent with the main analysis (all p interactions > 0.05). The abbreviations are the same as those in Figs. 1, 2, 3, 4

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840